
About Akshar Biotech Private Limited
Data last updated:
Akshar Biotech Private Limited is a private limited company based in Surat, Gujarat, India, recognised as a startup by DPIIT. It operates in the biofuel and biomass energy segment of the environmental services sector. It was incorporated on 05 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U29309GJ2017PTC097247. Its GSTIN is 24AAPCA5445B1ZW (Gujarat).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sonal Bharatbhai Savaliya and Sadhanaben Bharatbhai Savaliya.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at B1 – 302 River View Heights Pedar Road, Surat, Gujarat, India – 394101.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.57 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹27.68 Lakh (net margin 3.7%) and EBITDA of ₹39.62 Lakh (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 565% over three years.
The company has about 5 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Akshar Biotech. As per MCA filings, the company has open charges of ₹7 Cr on record. Court records list 3 cases involving the company, including 3 filed against it; 3 cases are pending.
Akshar Biotech Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-22-0074990). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aksharbiotech.in.
Company details
Recognitions & Rankings of Akshar Biotech
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-22-0074990
Contact details
Akshar Biotech Private Limited's registered office is in Surat, Gujarat. Its website is aksharbiotech.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressB1 – 302 River View Heights Pedar Road, Surat, Gujarat, India – 394101
- IndustryEnvironment, Biofuel & Biomass Energy
To see the full contact details of Akshar Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Akshar Biotech operates one associated brand: Akshar Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Biogas production from agricultural waste and by-products for energy and industrial uses. | aksharbiotech.in |
Business activity
The main business activities of Akshar Biotech are manufacturing and water supply, sewerage and waste management. In detail, this covers coke and refined petroleum products and waste collection, treatment and disposal activities, materials recovery and other waste management services. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C5 | Coke and refined petroleum products | |
| E | Water supply, sewerage and waste management | E3 | Waste collection, treatment and disposal activities, materials recovery and Other waste management services |
To see the full business activity and turnover split of Akshar Biotech Private Limited, buy the company report.
Financials of Akshar Biotech Private Limited
FY 2024 filings availableAkshar Biotech Private Limited reported revenue of ₹7.57 Cr (up 1681% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 565% over three years. EBITDA rose 329% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹39.62 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹27.68 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.2% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Akshar Biotech Private Limited, buy the company report.
Board of directors of Akshar Biotech Private Limited
Akshar Biotech has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sonal Bharatbhai Savaliya | Director | 01 Jul 2020 | 6 Years 3 Months | Current |
| Sadhanaben Bharatbhai Savaliya Also directs: Skylar Corporate Private Limited | Director | 01 Jul 2021 | 5 Years 3 Months | Current |
| Ramdas Lashkari | Director | 01 Jul 2021 | 5 Years 3 Months | Current |
| Bharatbhai Gabharubhai Savaliya Also directs: Aksharam Bioscience Technology LLP | Director | 05 May 2017 | 9 Years 5 Months | Current |
Peer comparison
Akshar Biotech Private Limited is compared with the 3 companies closest to it by revenue in the Cleantech industry (Biofuel and Biomass), with the same principal business activity (coke and refined petroleum products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kshumat Energy Private Limited | ₹7.63 Cr (FY 2024) | 36.0% | Mumbai, Maharashtra, India | |||
| Namberdar Bio Fuels Private Limited | ₹7.59 Cr (FY 2024) | Ghaziabad, Uttar Pradesh, India | ||||
| Akshar Biotech Private Limitedthis company | ₹7.57 Cr (FY 2025) | ₹27.68 Lakh | 3.7% | 1681.0% | 5 | Surat, Gujarat, India |
| Sun Bio-Fuels Private Limited | ₹7.44 Cr (FY 2025) | 76.0% | Tumkur, Karnataka, India |
To see the full peer comparison of Akshar Biotech Private Limited, buy the company report.
Auditor
Akshar Biotech Private Limited is audited by SKSN & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SKSN & CO. | FY 2023 | 158839W |
Shareholding
The shareholding of Akshar Biotech Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Akshar Biotech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Nov 2025 | 101195375 | Others | ₹7 Cr | Open |
Total charge records: 1 View all charges
Legal cases
Akshar Biotech Private Limited has 3 court cases on record: 3 filed against it. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 3 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Civil suit | Filed against the company by Wam India Pvt Ltd Through Siddhesh Joshi | Pending |
| District court, Thane, Maharashtra | Civil suit | Filed against the company by Wam India Pvt Ltd Through Siddhesh Joshi | Pending |
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed against the company by an individual | Pending |
To see the full case history of Akshar Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Akshar Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Akshar Biotech Private Limited has a workforce of 5 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
Akshar Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAPCA5445B1ZW | Gujarat | Active | 12 Jul 2019 |
To see the full GST registrations and return filing status of Akshar Biotech Private Limited, buy the company report.
Recent activity
Akshar Biotech Private Limited has 6 board changes on record since 2017: 4 appointments and 2 cessations. The latest: Yash Bharatbhai Savaliya ceased to be Director on 20 Sep 2024.
Frequently asked questions
Akshar Biotech is an active private limited company based in Surat, Gujarat, India. The company works in biofuel and biomass energy, within the environment industry. It was incorporated on 05 May 2017 (9+ years old) and is registered under CIN U29309GJ2017PTC097247.
Akshar Biotech has 4 current directors:
- Sonal Bharatbhai Savaliya - Director
- Sadhanaben Bharatbhai Savaliya - Director
- Ramdas Lashkari - Director
- Bharatbhai Gabharubhai Savaliya - Director
The latest financial statements of Akshar Biotech on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Akshar Biotech is 24AAPCA5445B1ZW, registered in Gujarat.
The CIN (Corporate Identification Number) of Akshar Biotech is U29309GJ2017PTC097247. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Akshar Biotech has 3 court cases on record: 3 filed against it. 3 are pending.
Akshar Biotech was incorporated on 05 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Akshar Biotech by revenue are Kshumat Energy Private Limited, Namberdar Bio Fuels Private Limited, Sun Bio-Fuels Private Limited, all in the Cleantech industry (Biofuel and Biomass), with the same principal business activity (coke and refined petroleum products).
Yash Bharatbhai Savaliya ceased to be Director on 20 Sep 2024. Ramdas Lashkari was appointed as Director on 01 Jul 2021. Sadhanaben Bharatbhai Savaliya was appointed as Director on 01 Jul 2021. Akshar Biotech has 6 board changes on record in total.
Yes, Akshar Biotech is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Akshar Biotech is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-22-0074990).